Published in Am J Physiol Lung Cell Mol Physiol on October 08, 2010
Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol (2011) 1.57
Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Respir Res (2011) 0.91
Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses (2012) 0.91
Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol (2013) 0.90
Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity. Am J Respir Cell Mol Biol (2014) 0.90
Human respiratory syncytial virus memphis 37 causes acute respiratory disease in perinatal lamb lung. Biores Open Access (2014) 0.82
Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants. PLoS One (2015) 0.80
Ontogeny of the immune response in the ovine lung. Immunol Invest (2011) 0.80
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection. BMC Res Notes (2014) 0.80
Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments. ILAR J (2014) 0.80
Exploiting ovine immunology to improve the relevance of biomedical models. Mol Immunol (2014) 0.78
RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function. J Gen Virol (2013) 0.77
Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants. Clin Microbiol (2015) 0.77
Immune exhaustion during chronic infections in cattle. J Vet Med Sci (2016) 0.75
Animal models of respiratory syncytial virus infection. Vaccine (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics (1998) 49.00
The B7 family revisited. Annu Rev Immunol (2005) 13.51
Type 1 interferons and the virus-host relationship: a lesson in détente . Science (2006) 6.33
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr (2003) 5.03
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A (2004) 4.75
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis (2007) 3.62
PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med (2003) 3.05
Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol (1998) 2.53
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol (2006) 2.43
Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J (1999) 2.03
Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol (2005) 1.87
Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol (1993) 1.74
Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev Med Virol (2006) 1.48
Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol (2006) 1.46
Acute otitis media and respiratory virus infections. Pediatr Infect Dis J (1989) 1.40
Human lung growth in late gestation and in the neonate. Am Rev Respir Dis (1984) 1.33
Respiratory tract viral infections in bone marrow transplant patients. Transplantation (2003) 1.29
Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol (2001) 1.26
A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J Virol (2009) 1.24
Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol (2008) 1.24
Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis (2005) 1.23
RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease. Eur J Immunol (2002) 1.21
Host transcription profiles upon primary respiratory syncytial virus infection. J Virol (2007) 1.19
Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A (2008) 1.16
Structure as revealed by airway dissection. A comparison of mammalian lungs. Am Rev Respir Dis (1983) 1.13
New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR. Biol Proced Online (2005) 1.08
Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int J Exp Pathol (2009) 1.08
Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol (2000) 1.06
The 'PREXCEL-Q Method' for qPCR. Int J Biomed Sci (2008) 1.06
Changes in alveolar epithelial cell proportions during fetal and postnatal development in sheep. Am J Physiol Lung Cell Mol Physiol (2003) 1.05
The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J Virol (2008) 1.04
Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. Dev Comp Immunol (2009) 1.00
Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J (2002) 1.00
Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol (2004) 0.95
Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q). Int J Biomed Sci (2009) 0.85
Development of alveolar septa and formation of alveolar pores during the early postnatal period in the rat lung. Acta Anat (Basel) (1988) 0.80
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J Biol Chem (2006) 1.79
Electrogram characteristics in postinfarction ventricular tachycardia: effect of infarct age. J Am Coll Cardiol (2005) 1.60
The need for transparency and good practices in the qPCR literature. Nat Methods (2013) 1.58
Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun (2002) 1.54
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care (2014) 1.48
Accuracy of electrocardiogram interpretation by cardiologists in the setting of incorrect computer analysis. J Electrocardiol (2006) 1.44
Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect (2004) 1.27
Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol (2004) 1.25
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood (2003) 1.14
Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis. J Infect Dis (2008) 1.13
Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol (2006) 1.11
Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions. Biol Proced Online (2006) 1.10
Human papillomavirus type 45 propagation, infection, and neutralization. Virology (2003) 1.09
New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR. Biol Proced Online (2005) 1.08
The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct. Cancer Immunol Immunother (2007) 1.08
The 'PREXCEL-Q Method' for qPCR. Int J Biomed Sci (2008) 1.06
Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model. PLoS One (2013) 1.06
Development of an in vivo RNAi protocol to investigate gene function in the filarial nematode, Brugia malayi. PLoS Pathog (2010) 1.03
Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. J Infect Dis (2011) 1.03
Immunologic indicators of clinical progression during canine Leishmania infantum infection. Clin Vaccine Immunol (2009) 1.02
Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia. Alcohol (2007) 1.02
Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. Dev Comp Immunol (2009) 1.00
Bachmann Bundle and its arterial supply: imaging with multidetector CT--implications for interatrial conduction abnormalities and arrhythmias. Radiology (2008) 0.99
Coordinated expression of tracheal antimicrobial peptide and inflammatory-response elements in the lungs of neonatal calves with acute bacterial pneumonia. Infect Immun (2003) 0.99
Expression of select immune genes (surfactant proteins A and D, sheep beta defensin 1, and toll-like receptor 4) by respiratory epithelia is developmentally regulated in the preterm neonatal lamb. Dev Comp Immunol (2006) 0.97
Differential expression of sheep beta-defensin-1 and -2 and interleukin 8 during acute Mannheimia haemolytica pneumonia. Microb Pathog (2004) 0.95
Developmental expression and distribution of sheep beta-defensin-2. Dev Comp Immunol (2004) 0.94
CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation. J Infect Dis (2006) 0.94
Surfactant protein D expression in normal and pneumonic ovine lung. Vet Immunol Immunopathol (2004) 0.93
Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res (2011) 0.92
Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs. J Clin Microbiol (2004) 0.92
Right atrial cavotricuspid isthmus: anatomic characterization with multi-detector row CT. Radiology (2008) 0.91
Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses (2012) 0.91
Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Respir Res (2011) 0.91
Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity. Am J Respir Cell Mol Biol (2014) 0.90
Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. Comp Med (2009) 0.89
Detection of phrenic nerves and their relation to cardiac anatomy using 64-slice multidetector computed tomography. Am J Cardiol (2007) 0.88
Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness. Pediatr Infect Dis J (2014) 0.88
Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of respiratory syncytial virus infection. Viral Immunol (2007) 0.88
Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol (2006) 0.86
Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 And IL-10 gene transcripts. Viral Immunol (2007) 0.86
Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection. Viral Immunol (2010) 0.86
Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q). Int J Biomed Sci (2009) 0.85
Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung. J Histochem Cytochem (2006) 0.84
Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet Immunol Immunopathol (2010) 0.84
The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice. Comp Med (2004) 0.84
Repeated intravenous doses of all-trans-retinoyl beta-D-glucuronide is not effective in the treatment of bacterial bronchopneumonia in lambs but is devoid of gross and acute toxicity. Med Sci Monit (2002) 0.84
Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease. Am J Vet Res (2012) 0.83
Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung. Alcohol (2010) 0.83
Mechanisms of ventricular arrhythmias in heart failure. Curr Heart Fail Rep (2005) 0.83
Cardiac conduction system: anatomic landmarks relevant to interventional electrophysiologic techniques demonstrated with 64-detector CT. Radiographics (2007) 0.83
Antimicrobial peptides and surfactant proteins in ruminant respiratory tract disease. Vet Immunol Immunopathol (2005) 0.83
Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV. PLoS One (2013) 0.81
Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments. ILAR J (2014) 0.80
Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells. Viruses (2013) 0.80
Effects of nicotine on pulmonary surfactant proteins A and D in ovine lung epithelia. Pediatr Pulmonol (2010) 0.80
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection. BMC Res Notes (2014) 0.80
Ontogeny of the immune response in the ovine lung. Immunol Invest (2011) 0.80
Increased anionic peptide distribution and intensity during progression and resolution of bacterial pneumonia. Clin Diagn Lab Immunol (2002) 0.79
Identification of candidate B-lymphoma genes by cross-species gene expression profiling. PLoS One (2013) 0.79
The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in mice. Antivir Ther (2008) 0.78
RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function. J Gen Virol (2013) 0.77
Characterization of a novel mouse model with genetic deletion of CD177. Protein Cell (2014) 0.77
Gene expression in intestinal mucosal biopsy specimens obtained from dogs with chronic enteropathy. Am J Vet Res (2012) 0.77
Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4. JCI Insight (2017) 0.77
Ontogeny of pulmonary cyclooxygenase-1 (COX-1) and -2 (COX-2). Pathophysiology (2011) 0.76
Posterior interatrial muscular connection between the coronary sinus and left atrium: anatomic and functional study of the coronary sinus with multidetector CT. Radiology (2011) 0.76